KRISTEN HAYES: Open Payments
NPI 1073223004 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 26 payments from 11 companies in 2025. Trend: 2023 $72 · 2024 $566 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $185 |
| ABBVIE INC. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Tris Pharma Inc | 1 | $21 |
| Lundbeck LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Auvelity, VRAYLAR, CAPLYTA, Jornay PM, UZEDY, TRINTELLIX, INGREZZA, Dyanavel XR.
Industry payments across VA — which companies pay providers there.
